Clinical Trial Update: The Efficacy Study of Aclasta on Prosthetic Fixation in Postmenopausal Women After THA [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating Aclasta for prosthetic fixation in postmenopausal women after cementless THA has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prosthetic Fixation After Cementless Total Hip Arthroplasty

Drugs mentioned

• Aclasta (zoledronic acid)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Prosthetic Fixation After Cementless Total Hip Arthroplasty | Phase 4 | Status: WITHDRAWN